G6S

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• arthralgia, aromatase inhibitor-induced [Insufficient Evidence]
• back pain [Insufficient Evidence]
• cancer [Insufficient Evidence]
• cardiovascular dz prevention [Insufficient Evidence]
• colorectal adenoma [Insufficient Evidence]
• colorectal CA [Insufficient Evidence]
• COVID-19 [Insufficient Evidence]
• dementia [Insufficient Evidence]
• depression [Insufficient Evidence]
• diabetes mellitus, type 2 [Insufficient Evidence]
• gout [Insufficient Evidence]
• heart failure [Insufficient Evidence]
• hyperlipidemia [Insufficient Evidence]
• inflammatory bowel dz [Insufficient Evidence]
• interstitial cystitis [Insufficient Evidence]
• joint pain [Insufficient Evidence]
• Kashin-Beck dz [Insufficient Evidence]
• knee pain [Insufficient Evidence]
• multiple sclerosis [Insufficient Evidence]
• nephrolithiasis [Insufficient Evidence]
• osteoarthritis [Likely Effective]
• overall mortality [Insufficient Evidence]
• postop recovery [Insufficient Evidence]
• rheumatoid arthritis [Insufficient Evidence]
• skin aging [Insufficient Evidence]
• stroke prevention [Insufficient Evidence]
• temporomandibular disorder [Insufficient Evidence]
• wound healing [Insufficient Evidence]